Jieer Ying

7PUBLICATIONS
83CO-AUTHORS
ChemotherapyTissue engineeringCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 01, 2025
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.

Keun-Wook Lee, Li-Yuan Bai, Minkyu Jung

|Jul 02, 2025
Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial.

Jingjing Li, Shurui Zhou, Xiaoqing Xu

|Apr 29, 2025
Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment.

Qing Wei, Teng Yang, Ziwen Zhang

|Dec 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.

Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang

|Dec 19, 2023
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration.

Qing Wei, Teng Yang, Jiayu Zhu

|Apr 18, 2023
Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy.

Qi Xu, Xiaoqing Xu, Haimeng Tang

Pageof 2

Frequent Collaborators

2 joint publications

Qing Wei

2 joint publications

Takaya Shimura

2 joint publications

Ziwen Zhang

2 joint publications

Teng Yang